Nicholas Chan

Dr. Nicholas Chan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2024 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
NCNicholas Chan
Nicholas Chan
STSergio Teruya
Sergio Teruya
AMAlfonsina Mirabal
Alfonsina Mirabal
AWAriel Y. Weinsaft
Ariel Y. Weinsaft
JSJeffeny DE Los Santos
Jeffeny DE Los Santos
MMMathew S. Maurer
Mathew S. Maurer

2 January 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
DHDiarmaid Hughes
Diarmaid Hughes
AAAli Aminian
Ali Aminian
CTChao Tu
Chao Tu
YOYuichiro Okushi
Yuichiro Okushi
YSYoshihito Saijo
Yoshihito Saijo
BXBo Xu
Bo Xu
Background: Obesity leads to an increased risk of cardiovascular disease morbidity and death, including heart failure. Bariatric surgery has been proven to be the most effective long‐term weight management treatment. This study investigated the changes in cardiac structure and function after bariatric surgery, including left ventricular global longitudinal strain. Methods and Results: There were 398 consecutive patients who underwent bariatric surgery with pre‐ and postoperative transthoracic echocardiographic imaging at a US health system between 2004 and 2019. We compared cardiovascular risk factors and echocardiographic parameters between baseline and follow‐up at least 6 months postoperatively. Along with decreases in weight postoperatively, there were significant improvements in cardiovascular risk factors, including reduction in systolic blood pressure levels from 132 mm Hg (25th–75th percentile: 120–148 mm Hg) to 127 mm Hg (115–140 mm Hg; P =0.003), glycated hemoglobin levels from 6.5% (5.9%–7.6%) to 5.7% (5.4%–6.3%; P <0.001), and low‐density lipoprotein levels from 97 mg/dL (74–121 mg/dL) to 86 mg/dL (63–106 mg/dL; P <0.001). Left ventricular mass decreased from 205 g (165–261 g) to 190 g (151–236 g; P <0.001), left ventricular ejection fraction increased from 58% (55%–61%) to 60% (55%–64%; P <0.001), and left ventricular global longitudinal strain improved from −15.7% (−14.3% to −17.5%) to −18.6% (−16.0% to −20.3%; P <0.001) postoperatively. Conclusions: This study has shown the long‐term impact of bariatric surgery on cardiac structure and function, with reductions in left ventricular mass and improvement in left ventricular global longitudinal strain. These findings support the cardiovascular benefits of bariatric surgery.

1 December 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
YSYoshihito Saijo
Yoshihito Saijo
NCNicholas Chan
Nicholas Chan
MBMaria Vega Brizneda
Maria Vega Brizneda
HLHassan Mehmood Lak
Hassan Mehmood Lak
RRReza M. Reyaldeen
Reza M. Reyaldeen
BXBo Xu
Bo Xu

1 August 2023 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
TWTom Kai Ming Wang
Tom Kai Ming Wang
DKDuygu Kocyigit
Duygu Kocyigit
HCHarry Choi
Harry Choi
CAChris M. Anthony
Chris M. Anthony
NCNicholas Chan
Nicholas Chan
DKDeborah H. Kwon
Deborah H. Kwon
BACKGROUND: The severity classification of functional mitral regurgitation (FMR) remains controversial despite adverse prognosis and rapidly evolving interventions. Furthermore, it is unclear if quantitative assessment with cardiac magnetic resonance can provide incremental risk stratification for patients with ischemic cardiomyopathy (ICM) or non-ICM (NICM) in terms of FMR and late gadolinium enhancement (LGE). We evaluated the impact of quantitative cardiac magnetic resonance parameters on event-free survival separately for ICM and NICM, to assess prognostic FMR thresholds and interactions with LGE quantification. METHODS: Patients (n=1414) undergoing cardiac magnetic resonance for cardiomyopathy (ejection fraction<50%) assessment from April 1, 2001 to December 31, 2017 were evaluated. The primary end point was all-cause death, heart transplant, or left ventricular assist device implantation during follow-up. Multivariable Cox analyses were conducted to determine the impact of FMR, LGE, and their interactions with event-free survival. RESULTS: There were 510 primary end points, 395/782 (50.5%) in ICM and 114/632 (18.0%) in NICM. Mitral regurgitation-fraction per 5% increase was independently associated with the primary end point, hazards ratios (95% CIs) of 1.04 (1.01–1.07; P =0.034) in ICM and 1.09 (1.02–1.16; P =0.011) in NICM. Optimal mitral regurgitation-fraction threshold for moderate and severe FMR were ≥20% and ≥35%, respectively, in both ICM and NICM, based on the prediction of the primary outcome. Similarly, optimal LGE thresholds were ≥5% in ICM and ≥2% in NICM. Mitral regurgitation-fraction×LGE emerged as a significant interaction for the primary end point in ICM ( P =0.006), but not in NICM ( P =0.971). CONCLUSIONS: Mitral regurgitation-fraction and LGE are key quantitative cardiac magnetic resonance biomarkers with differential associations with adverse outcomes in ICM and NICM. Optimal prognostic thresholds may provide important clinical risk prognostication and may further facilitate the ability to derive selection criteria to guide therapeutic decision-making.

23 November 2024 in The American Journal of Cardiology
Verified
Journal Article
Closed access
NCNicholas Chan
Nicholas Chan
AEAndrew J. Einstein
Andrew J. Einstein
STSergio Teruya
Sergio Teruya
CRCarlos Rodriguez
Carlos Rodriguez
SHStephen Helmke
Stephen Helmke
FRFrederick L. Ruberg
Frederick L. Ruberg

5 July 2023 in Life
Verified
Journal Article
Open access
PDF file
NCNicholas Chan
Nicholas Chan
TDTiffany Dong
Tiffany Dong
NSNabil Sabbak
Nabil Sabbak
BXBo Xu
Bo Xu
TWTom Kai Ming Wang
Tom Kai Ming Wang
Mitral regurgitation (MR) is the most common form of valvular heart disease in the United States, and there are established guidelines for indications for requiring mitral valve surgeries. However, there is an unmet clinical need for a subset of high-risk MR patients, especially those with advanced age, heart failure and/or secondary MR. Following the successes of transcatheter aortic valve replacements, significant advances have occurred over the last decade in transcatheter mitral valve interventions in order to manage these patients in both clinical practice and trials. The three main types of these interventions include a transcatheter edge-to-edge repair, percutaneous mitral annuloplasty (both direct and indirect) and transcatheter mitral valve replacement (including when applied to a prior prosthetic valve, annuloplasty ring and mitral annuloplasty ring). This review aims to discuss the contemporary techniques, evidence, indications, multimodality imaging evaluations and outcomes of the various transcatheter mitral valve interventions.